Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

198
The pathophysiology of pneumonia involves the following steps:
198
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and characterization of mouse-adapted recombinant SARS-CoV-2 expressing reporter genes.

Microbiology spectrum·2026
Same author

LRP4 is an entry receptor for multiple encephalitic alphaviruses.

Nature communications·2026
Same author

Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape.

PLoS pathogens·2026
Same author

How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023.

BMJ open·2026
Same author

Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes.

The Lancet. Respiratory medicine·2026
Same author

Design of a neutralizing and protective pan-encephalitic alphavirus receptor decoy protein.

Science translational medicine·2026

Related Experiment Video

Updated: May 24, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.6K

Lung inflammation drives Long Covid.

Alan Sariol1, Stanley Perlman2

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Science (New York, N.Y.)
|March 6, 2025
PubMed
Summary

Peroxisome dysfunction in macrophages hinders lung repair following COVID-19 infection in mice. This cellular defect compromises the body's ability to recover lung tissue after the disease.

Area of Science:

  • Cellular Biology
  • Immunology
  • Respiratory Medicine

Background:

  • COVID-19 can lead to significant lung damage and impaired repair mechanisms.
  • Macrophages play a critical role in tissue repair and inflammation resolution.
  • Peroxisomes are vital organelles involved in various metabolic processes, including oxidative stress management.

Purpose of the Study:

  • To investigate the role of peroxisome dysfunction in macrophage-mediated lung repair after COVID-19.
  • To determine the impact of impaired peroxisome function on the inflammatory and regenerative processes in the lungs.

Main Methods:

  • Utilized a mouse model of COVID-19 to study lung pathology and repair.
  • Employed genetic and pharmacological approaches to induce or inhibit peroxisome dysfunction in macrophages.

More Related Videos

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

7.3K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

6.9K

Related Experiment Videos

Last Updated: May 24, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.6K
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

7.3K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

6.9K
  • Analyzed macrophage function, inflammatory markers, and tissue regeneration in the lungs.

    • Main Results:

    • Peroxisome dysfunction in macrophages significantly impaired lung tissue repair in mice post-COVID-19.
    • Mice with dysfunctional peroxisomes exhibited heightened inflammation and reduced regenerative capacity in the lungs.
    • Specific molecular pathways linking peroxisome function to macrophage-mediated repair were identified.

    Conclusions:

    • Dysfunctional peroxisomes in macrophages are a key factor limiting lung recovery after COVID-19.
    • Targeting peroxisome function in macrophages may represent a novel therapeutic strategy for improving lung repair in COVID-19 survivors.